After publication of the draft Generally Regarded As Safe (GRAS) rule in 1977, the United States Food and Drug Administration (FDA) initiated an Interim Pilot Program encouraging the notification to FDA of GRAS determinations. This presentation analyzes GRAS notifications submitted during the Interim Pilot program along with warning letters issued during the same time period to better understand the evolution of the program and anticipate the future GRAS landscape. This webinar replay expires May 23, 2019.
Review how virtual / remote patient research approaches work, how our industry (pharma, regulators, academic researchers) is supporting this change, and what you can do to adopt this approach. Webinar Replay expires March 28, 2019.
Barry Lake, CEO of Devana Solutions®, a cloud-based operations and data analytics platform for research sites and networks, will provide insights into timing and performance metrics data that sites can leverage to position themselves as sector leaders and enhance valuation for a successful exit sale. Webinar replay expires March 28, 2019.
This webinar will allow attendees to better understand the future landscape of paperless clinical trials and how to “separate toys from tools” when choosing mobile and related devices. Webinar Replay Expires March 7, 2019.
The clinical research landscape is constantly changing with ebbs and flows in amount of clinical trials being conducted in a given therapeutic area or indication. With this shifting landscape, how do clinical research sites put themselves in the best position for long term success? – Webinar Replay Expires January 24, 2019.
